Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
BMY.RT was delisted on the 31st of December, 2020.
8 hedge funds and large institutions have $6.4M invested in Bristol-Myers Squibb Company Contingent Value Rights in 2021 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 6 closing their positions.
22% more capital invested
Capital invested by funds: $5.25M → $6.4M (+$1.16M)
33% less funds holding
Funds holding: 12 → 8 (-4)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BC
Brookfield Corp
Toronto,
Ontario, Canada
|
-$410K |
| 2 |
TNB
Thomasville National Bank
Thomasville,
Georgia
|
-$146K |
| 3 |
WAM
Westport Asset Management
Southport,
Connecticut
|
-$7K |
| 4 |
IAIM
International Assets Investment Management
Orlando,
Florida
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
JCI
1
Jet Capital Investors
New York
| $3.46M | – | – | – |
|
2
Tudor Investment Corp
Stamford,
Connecticut
| $2.94M | – | – | – |
|
|
BC
3
Brookfield Corp
Toronto,
Ontario, Canada
| – | -$410K | -400,000 | Closed |
|
|
TNB
4
Thomasville National Bank
Thomasville,
Georgia
| – | -$146K | -38,459 | Closed |
|
|
WAM
5
Westport Asset Management
Southport,
Connecticut
| – | -$7K | -10,000 | Closed |
|
|
IAIM
6
International Assets Investment Management
Orlando,
Florida
| – | -$2K | -2,375 | Closed |
|
BMY.RT Hedge Fund Activity: Q2 2021 in Review
8 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) for Q2 2021, worth a combined $6.4M — up 22% from $5.25M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of BMY.RT and 2 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Brookfield Corp, exiting entirely with an estimated $410K sold.
- 8 institutional investors held Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) as of Q2 2021, down from 12 in Q1 2021.
- Funds reported $6.4M of Bristol-Myers Squibb Company Contingent Value Rights stock for Q2 2021, up 22% quarter-over-quarter.
- 2 funds opened new Bristol-Myers Squibb Company Contingent Value Rights positions in Q2 2021 and 6 closed out, a net change of -4 holders.
- The largest Bristol-Myers Squibb Company Contingent Value Rights seller in Q2 2021 was Brookfield Corp, an estimated $410K sold.
Based on aggregated 13F filings for Q2 2021.